Brief: Impel Pharmaceuticals Presents New Data At AAN 2023 Suggesting Trudhesa Nasal Spray Is Safe To Use
26/04/2023 13:18
April 26 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS PRESENTS NEW DATA AT AAN 2023
SUGGESTING
TRUDHESA® NASAL SPRAY IS SAFE TO USE WHEN CO-ADMINISTERED WITH
COMMONLY PRESCRIBED MIGRAINE MEDICATIONS
* IMPEL PHARMACEUTICALS- ANALYSES FROM STOP 301 TRIAL SHOW
CONCOMITANT USE OF TRUDHESA WITH TRIPTANS & PREVENTATIVE CGRP,
ERENUMAB, WERE WELL-TOLERATED
Source text for Eikon: ID:nGNX8WB01
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq